Birdwatch Note Rating
2023-03-16 00:58:42 UTC - NOT_HELPFUL
Rated by Participant: 99E1F5AFED5B83E5AAEFEBFB9AFCE4DB7718D49C2BBAE382526716F61E9C4B2C
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details